Nutra Pharma Corp (NPHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,062 | -2,302 | -4,162 | -165 | -2,431 |
| Depreciation Amortization | 15 | 6 | 6 | N/A | 23 |
| Accounts receivable | -5 | -240 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 606 | -52 | -39 | -22 | -5 |
| Other Working Capital | 320 | -333 | 224 | 9 | 20 |
| Other Operating Activity | 767 | 964 | 2,995 | -627 | 656 |
| Operating Cash Flow | $-1,358 | $-1,956 | $-976 | $-805 | $-1,737 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -72 | -8 | N/A | N/A | -10 |
| Net Acquisitions | N/A | N/A | 40 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -300 | -2 | 0 |
| Investing Cash Flow | $-72 | $-8 | $-260 | $-2 | $-10 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 535 | 547 | 464 | 791 | 1,075 |
| Debt Repayment | -407 | -931 | -109 | N/A | N/A |
| Common Stock Issued | 500 | 3,100 | 809 | 120 | 622 |
| Financing Cash Flow | $627 | $2,716 | $1,164 | $911 | $1,697 |
| Beginning Cash Position | 803 | 51 | 123 | 19 | 69 |
| End Cash Position | N/A | 803 | 51 | 123 | 19 |
| Net Cash Flow | $-803 | $752 | $-72 | $104 | $-50 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,358 | -1,956 | -976 | -805 | -1,737 |
| Capital Expenditure | -72 | -8 | N/A | N/A | -10 |
| Free Cash Flow | -1,430 | -1,964 | -976 | -805 | -1,747 |